Immunome IMNM
NASDAQ IMNM
$17.92 +1.15 (+6.86%)
At close: Oct 20, 2026 · 4:00 PM EDT

Immunome (IMNM) Revenue (2019 - 2025)

Updated

Immunome's Revenue was $6.94 million in FY2025, down 23.2% from $9.04 million in FY2024.

Analysis

Immunome (IMNM) Revenue (2019 - 2025) Analysis & Trends

  • Per Business Quant data, Revenue in earlier years was $9.04 million in FY2024 (-35.5%) and $14.02 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 25.31 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 16.99 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 15.38 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 15.03 Bn
10 Immunome 2.04 Bn 6.69 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 4.02 Mn
Mar 31, 2025 2.93 Mn
Dec 31, 2024 2.74 Mn
Sep 30, 2024 2.91 Mn
Jun 30, 2024 2.36 Mn
Mar 31, 2024 1.03 Mn
Dec 31, 2023 3.83 Mn
Sep 30, 2023 3.57 Mn
Jun 30, 2023 4.26 Mn
Mar 31, 2023 2.36 Mn
Dec 31, 2022 1,000.00
Sep 30, 2022 1,000.00
Jun 30, 2022 2,000.00
Mar 31, 2022 1,000.00
Dec 31, 2021 -5,000.00
Sep 30, 2021 -3,000.00
Jun 30, 2021 -1,000.00
Mar 31, 2021 -1,000.00
Dec 31, 2020 -11,000.00
Sep 30, 2020 -10,000.00
API Access

Immunome Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=IMNM&period=max&api_key=YOUR_API_KEY